Sun Pharma Global Fze recalls buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed…
- Recall date
- July 17, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1345-2015
- FDA classification
- Class III
- Brand / firm
- Sun Pharma Global Fze
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86
Get recall alerts
Free email alert whenever Sun Pharma Global Fze has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sun Pharma Global Fze